ClearBridge Large Cap Growth Strategy’s Thoughts on Eli Lilly and Company (LLY)

3 days ago 5

Soumya Eswaran

Thu, January 8, 2026 astatine 7:16 AM CST 3 min read

ClearBridge Investments, an concern absorption company, released its “ClearBridge Large Cap Growth Strategy” fourth-quarter 2025 capitalist letter. The concern doctrine of the strategy is to put successful starring companies that are undervalued by the marketplace successful presumption of their aboriginal maturation potential. A transcript of the missive tin beryllium downloaded here. Large-cap stocks continued their spot successful the quarter, driven by beardown net maturation from mega-cap companies and enthusiasm implicit generative AI. The ClearBridge Large Cap Growth Strategy underperformed the Russell 1000 Growth Index by astir 900 ground points for the year. It continued to lag down the benchmark, trailing its 1.2% quarterly beforehand by astir 170 ground points during the 4th quarter. The underweight vulnerability to mega-cap AI beneficiaries and lower-quality AI-related names contributed to the underperformance. In addition, delight cheque the fund’s apical 5 holdings to cognize its champion picks successful 2025.

In its fourth-quarter 2025 capitalist letter, ClearBridge Large Cap Growth Strategy highlighted stocks specified arsenic Eli Lilly and Company (NYSE:LLY). Eli Lilly and Company (NYSE:LLY) is simply a pharmaceutical institution headquartered successful Indianapolis, Indiana. The one-month instrumentality of Eli Lilly and Company (NYSE:LLY) was 9.78%, and its shares gained 40.76% of their worth implicit the past 52 weeks. On January 7, 2026, Eli Lilly and Company (NYSE:LLY) banal closed astatine $1,108.09 per share, with a marketplace capitalization of $993.355 billion.

ClearBridge Large Cap Growth Strategy stated the pursuing regarding Eli Lilly and Company (NYSE:LLY) successful its 4th fourth 2025 capitalist letter:

"We were excessively aboriginal successful exiting pharmaceutical shaper Eli Lilly and Company (NYSE:LLY), which we sold successful July astatine what we viewed arsenic just worth and owed to uncertainty implicit reimbursements for GLP-1 treatments for diabetes and obesity and the continued prevalence of lower-priced competition. Since then, the U.S. authorities has struck a woody with Lilly to connection GLP-1s to Medicare and Medicaid patients, opening up millions of further prescriptions, portion readouts connected the company’s oral GLP-1 attraction indicated a broader marketplace than we had expected. Lilly shares surged successful the 4th quarter, causing our deficiency of vulnerability to beryllium a resistance connected comparative results."

Was Jim Cramer Right About Eli Lilly and Company (LLY)?

Eli Lilly and Company (NYSE:LLY) is successful 21st presumption connected our database of 30 Most Popular Stocks Among Hedge Funds. According to our database, 114 hedge money portfolios held Eli Lilly and Company (NYSE:LLY) astatine the extremity of the 3rd quarter, compared to 119 successful the erstwhile quarter. In the 3rd 4th of 2025, Eli Lilly and Company’s (NYSE:LLY) revenue grew 54% compared to the aforesaid play past year. While we admit the imaginable of Eli Lilly and Company (NYSE:LLY) arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.